Roche Bobois S.A. : The upward trend should continue
Entry price | Target | Stop-loss | Potential |
---|
€25.5 |
€29.7 |
€22 |
+16.47% |
---|
Market participant are once again showing interest in shares in Roche Bobois S.A.. The technical chart pattern now appears positive for the short term with new upside potential.
Summary● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.